UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006448
Receipt number R000007655
Scientific Title Characteristics of Japanese asthmatics with severe exacerbation, -Nationwide, multicenter, prospective study-
Date of disclosure of the study information 2011/10/03
Last modified on 2013/01/09 10:00:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Characteristics of Japanese asthmatics with severe exacerbation, -Nationwide, multicenter, prospective study-

Acronym

Characteristics of Japanese asthmatics with severe exacerbation

Scientific Title

Characteristics of Japanese asthmatics with severe exacerbation, -Nationwide, multicenter, prospective study-

Scientific Title:Acronym

Characteristics of Japanese asthmatics with severe exacerbation

Region

Japan


Condition

Condition

Bronchial asthma

Classification by specialty

Pneumology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the characteristics of patients with severe asthma attacks, such as backgrounds, risk factors, circumstances, triggers, symptoms and signs.

To explore the characteristics related to time to maintain the SpO2 level of >90% for 24 hours after admission, hospitalization period, time to wean from oxygen, and occurrence of near fatal asthma.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Time to maintain the SpO2 level of >90% for 24 hours after admission

Key secondary outcomes

- Hospitalization period
- Time to wean form oxygen therapy
- Occurrence of near-fatal asthma


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

- Patients requiring hospitalization due to severe asthma attacks
- Patients with SpO2 of =< 90% on room air at the time of hospitalization or transportation before treatment

Key exclusion criteria

- Patients requiring hospitalization due to any reason other than asthma attacks
- Patients ruled out by investigators due to ineligibilities

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Tanaka

Organization

Sapporo Medical University

Division name

3rd Dept.of Internal Medicine, School of Medicine

Zip code


Address

S1W16, Chuo-ku, Sapporo

TEL

011-611-2111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Masaru Fujii

Organization

Sapporo Medical University

Division name

3rd Dept.of Internal Medicine, School of Medicine

Zip code


Address

S1W16, Chuo-ku, Sapporo

TEL

011-611-2111

Homepage URL


Email

mafuji@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical University

Institute

Department

Personal name



Funding Source

Organization

Foundation for Biomedical Research and Innovation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Translational Research Informatics Center, Foundation for Biomedical Research and Innovation

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

札幌医科大学附属病院
藤沢市民病院
国立病院機構相模原病院
東海大学医学部附属病院
トヨタ記念病院
JA愛知厚生連 豊田厚生病院
大津赤十字病院
神戸市立医療センター 中央市民病院
大阪府済生会中津病院
国立病院機構福岡病院
置賜広域病院組合 公立置賜総合病院
亀田総合病院
横浜市立大学附属市民総合医療センター
国立国際医療研究センター病院
富岡地域医療事務組合公立富岡総合病院
医療法人豊田会 刈谷豊田総合病院
静岡県立総合病院
兵庫県立尼崎病院


Other administrative information

Date of disclosure of the study information

2011 Year 10 Month 03 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 20 Day

Date of IRB


Anticipated trial start date

2011 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

A prospective observational study of
identifying the characteristics of patients with severe asthma attacks, as well as exploring the characteristics related to time to maintain the SpO2 level of >90% for 24 hours after admission, hospitalization period, time to wean from oxygen, and occurrence of near fatal asthma


Management information

Registered date

2011 Year 09 Month 30 Day

Last modified on

2013 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007655


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name